Ilan Ganot - May 2, 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
May 2, 2024
Transactions value $
-$4,772
Form type
4
Date filed
5/6/2024, 06:48 PM
Previous filing
Feb 16, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Options Exercise +1.55K +18.45% 9.97K May 2, 2024 Wife F1
transaction SLDB Common Stock Sale -$4.77K -462 -4.63% $10.33 9.51K May 2, 2024 Wife F2
holding SLDB Common Stock 94.8K May 2, 2024 Direct F3
holding SLDB Common Stock 19.4K May 2, 2024 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Options Exercise $0 -1.55K -100% $0.00* 0 May 2, 2024 Common Stock 1.55K Wife F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units. This sale does not represent a discretionary trade by Ms. Ganot.
F3 Represents 90,765 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F4 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F5 The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.